SCHEMBL13099565

SCHEMBL13099565

O=C(Nc1ccc(Br)c(C(F)(F)F)c1)[C@H]1CC=C[C@H]2CCN(Cc3ccccc3)C(=O)[C@@H]12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 2/20 0.83
▸ HCRTR1 O43613 2/20 0.66
▸ ALDH1A1 P00352 2/20 0.49
▸ PREP P48147 3/20 0.45
▸ MAPT P10636 4/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ FPR3 P25089 1/20 0.40
▸ FPR2 P25090 1/20 0.40
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ EPHX1 P07099 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ MET P08581 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ XBP1 P17861 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13397525 1.00 OPRK1 (0.83) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13108371 1.00 OPRK1 (0.83) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13397568 0.91 OPRK1 (0.69) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13099539 0.91 OPRK1 (1.00) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13099569 0.91 OPRK1 (1.00) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13099552 0.91 OPRK1 (1.00) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13108374 0.91 OPRK1 (1.00) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13108382 0.91 OPRK1 (1.00) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13099573 0.91 OPRK1 (1.00) OPRK1HCRTR1ALDH1A1PREPMAPT
SCHEMBL13099594 0.90 OPRK1 (0.83) OPRK1HCRTR1ALDH1A1PREPMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243333-A1 SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS UNIVERSITY OF KANSAS (US) 2014-08-28 — — US disclosed
US-20140243333-A1 SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS UNIVERSITY OF KANSAS (US) 2014-08-28 — — US disclosed
US-8735391-B2 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods UNIVERSITY OF KANSAS (US) 2014-05-27 — — US disclosed
US-8735391-B2 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods UNIVERSITY OF KANSAS (US) 2014-05-27 — — US disclosed
US-20100256142-A1 SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8- CARBOXAMIDES, OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS UNIVERSITY OF NORTH CAROLINA 2010-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256142-A1 SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8- CARBOXAMIDES, OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS OPRM1, OPRK1, OPRL1 OPRK1 2/4885HCRTR1 14/4885ALDH1A1 131/4885
US-20140243333-A1 SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS OPRM1, OPRK1, OPRD1 OPRK1 2/4885HCRTR1 33/4885ALDH1A1 109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback